Urothelial Carcinoma Recurrence at an Ileal Orthotopic Neobladder and Unilateral Lower Ureter After Surgery  by Kawamoto, Bunya et al.
Contents lists available at ScienceDirect
Urology Case Reports
journal homepage: www.elsevier .com/locate/eucr
Urology Case Reports 9 (2016) 27e29OncologyUrothelial Carcinoma Recurrence at an Ileal Orthotopic Neobladder
and Unilateral Lower Ureter After Surgery
Bunya Kawamoto, Masashi Honda*, Hideto Iwamoto, Shuichi Morizane, Katsuya Hikita,
Atsushi Takenaka
Division of Urology, Department of Surgery, Tottori University Faculty of Medicine, Yonago, Japana r t i c l e i n f o
Article history:
Received 6 July 2016
Received in revised form
30 July 2016





AdenocarcinomaFunding: This research did not receive any speciﬁc gr
the public, commercial, or not-for-proﬁt sectors.
* Corresponding author. Division of Urology, Dep
University Faculty of Medicine, 86, Nishi-cho, Yonag
Fax: þ81 859 38 6609.
E-mail address: honda@med.tottori-u.ac.jp (M. Hon
2214-4420/ 2016 The Authors. Published by Elsevier
http://dx.doi.org/10.1016/j.eucr.2016.08.003a b s t r a c t
The recurrence of urothelial carcinoma in an orthotopic neobladder is rare. We report the case of a 61-
year-old man with a muscle-invasive bladder tumor that was treated using radical cystectomy and the
creation of a Studer’s orthotopic neobladder. However, nine years after the cystectomy, we detected a
mass at the left ureteroileal anastomosis. We successfully performed Studer’s neobladder resection,
urethrectomy, and left nephroureterectomy to remove the entire mass. Pathological examination
revealed urothelial carcinoma with adenocarcinoma in the neobladder and adenocarcinomatous
metastasis in the mesenteric lymph node.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Radical cystectomy (RC) with lymph node (LN) dissection is the
standard treatment for muscle-invasive bladder tumors. Among
patients who are <80 years old and have preserved renal function,
an orthotopic ileal neobladder is often created as a urinary
diversion. In case of orthotopic urinary diversion, some patients
experience recurrence in the upper tract or urethra.1 A recent study
of urethral recurrence after RC and orthotopic urinary diversion for
bladder urothelial carcinoma (UC) reported a recurrence rate of
0.5%-17.2%, and most of these recurrences occurred within 5 years.1
However, there are few reports regarding recurrence in urinary
diversions that use the colon, and only sporadic reports have
described recurrence with metastasis to the LN. Therefore, we
report a rare case of UC recurrence at an orthotopic ileal neobladder
and the lower ureter, as well as our successful surgical treatment.
Case presentation
A 61-year-old man underwent a radical cystoprostatectomy,
with the creation of a Studer’s orthotopic neobladder, for aant from funding agencies in
artment of Surgery, Tottori
o, Tottori 683-8503, Japan.
da).
Inc. This is an open access article umuscle-invasive bladder tumor. The histopathological ﬁndings
from this procedure suggested UC (grade 3, stage pTis) without LN
metastasis and prostate adenocarcinoma with a Gleason score of 7.
After surgery, the patient was followed-up using urine cytology
testing and imaging at regular intervals. Nine years after the
surgery, cytology tests revealed abnormal results and computed
tomography (CT) revealed neobladder wall thickening around the
left ureteroileal anastomosis and anastomotic stenosis (Fig. 1A).
Furthermore, we detected left hydronephrosis, although no eleva-
tions in the serum levels of prostate-speciﬁc antigen were detected
during this period. Cystoscopy also revealed irregular mucosa in the
orthotopic neobladder and a mass at the left ureteroileal anasto-
mosis (Fig. 1B). At that time, there were no signs of metastatic or
other neoplastic diseases.
We performed a random biopsy of the neobladder and observed
carcinoma in situ (pTis at the neobladder neck away from the
urothelium and non-invasive pTa UC at the left ureteroileal anas-
tomosis). Thus, we performed resection of the Studer neobladder,
urethrectomy, and left nephroureterectomy to remove the entire
tumor, and we also performed a right ureterocutaneostomy. Path-
ological examinations revealed UC in the left ureter (grade 3, stage
pTis), adenocarcinoma (AC) and UC in the neobladder (grade 3, INF
g, stage pT2b), and ACmetastasis in themesenteric LNs (Fig. 2AeD).
Based on the detection of the LN metastasis, we also treated the
patient with 9 courses of adjuvant chemotherapy (1700 mg gem-
citabine and 300mg carboplatin). The patient has been followed-up
using urine cytology (every 3months) and CT (every 6months), andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Computed tomography ﬁndings at 9 years after radical cystoprostatectomy. (A) The neobladder wall was thickened and enhanced at the left ureteral anastomosis, and
(B) the left ureteral anastomosis was swollen with degeneration of the irregular mucosa.
Figure 2. The resected specimen from the left kidney, ureter, neobladder, and urethra. (A) The whole specimen. Pathological evaluation detected urothelial carcinoma in the ureter
(B) and in the neobladder (C), with adenocarcinomatous lymph node metastasis (D).
B. Kawamoto et al. / Urology Case Reports 9 (2016) 27e2928
B. Kawamoto et al. / Urology Case Reports 9 (2016) 27e29 29no recurrence or metastasis has been detected during the
20 months after the operation.
Discussion
We described a rare case of recurrent UC at the intestinal
epithelium that included the ureteroileal anastomosis, and AC with
LNmetastasis. As in the present case, an orthotopic ileal neobladder
is often used for urinary diversion, although patient selection is
critical for the success of this approach. For example, it is necessary
to conﬁrm that there is no invasion into the urethra, and the patient
must be willing and able to maintain the reservoir, regardless
of their medical or psychosocial status.2 The reported incidence of
urethral recurrence after RC is 0.5%-17.2%, and the overall incidence
is 8.1%, although most cases of recurrence in the urethra are iden-
tiﬁed within 5 years after RC.
There are few reports regarding UC recurrence in the bowel
segment, although there are two theories regarding the mechanism
of UC recurrence. The ﬁrst theory is “ﬁeld carcinogenesis”; tumor
cells (especially carcinoma in situ) with malignant genetic proﬁles
exist in the apparently normal urothelium, and the non-malignant
but genetically abnormal cells spread throughout the epithelium
around the visible UC, where they eventually and independently
develop into overt tumors.3 The second theory is “seed and im-
plantation”. In the normal urinary tract, papillary tumors of the
upper tract frequently recur in the bladder (15%-50%), and some
cases have proven that urothelial tumor cells originated in the renal
pelvis, which is the source of the “seed and implantation”.4 In the
present case, the UC recurred in the intestinal mucosa, but not in
the urothelium, which appears to support the “seed and
implantation” theory.
Primary bladder AC is a rare histologic variant, with a reported
incidence of 0.5%-2% among all bladder cancers.5 The risk factors for
this variant include bladder exstrophy, schistosomiasis, chronic
irritation, obstruction, cystocele, and endometriosis. Secondary
bladder AC is more common compared to primary AC, and it may
arise from the colorectum, prostate, stomach, lungs, or other sites
via direct extension or the hematogenous or lymphatic route.5
Therefore, we suspect that the tumor in the present case origi-
nated as UC in the left lower ureter and spread to the bladder via the
“seed and implantation” route, and then the UC in the orthotopic
neobladder was modiﬁed to AC by chronic irritation.It is also notable that the AC spread from the orthotopic neo-
bladder to themesenteric LN. Thus, appropriate staging of recurrent
UC in an orthotopic neobladder is difﬁcult, especially in cases with
LN metastasis. For example, metastasis to only the lesional LNs (eg,
the common, internal, and external iliac LNs) may be considered
normal bladder cancer, although it is unclear how to address
metastasis to the mesenteric LNs (as in this case). If the mesenteric
LN is included with the regional LNs, the present case would be
considered similar to normal UC (pN1M0), although metastases are
considered distant (pN0M1) if the mesenteric LN is considered
separate from the regional LNs. Moreover, if the recurrence in the
intestinal tissue is considered an intestinal tumor, this case would
be considered pT2N1M0 (stage IIIA), under the TNM classiﬁcation
for small intestinal cancer. Therefore, this very rare case highlights
the importance of discussing the management of recurrent UC with
LN metastasis.Conclusion
Although UC recurrence in an orthotopic neobladder is unusual,
we successfully resected the orthotopic neobladder using unilateral
nephroureterectomy. However, we identiﬁed adenocarcinomatous
metastasis in the mesenteric LN, which highlights the need for
further discussion regarding the oncological classiﬁcation of this
type of tumor.Conﬂict of interest
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